Literature DB >> 19572697

Tunable layer-by-layer polyelectrolyte platforms for comparative cell assays.

Jinhwa Seo1, Hyojin Lee, Jongho Jeon, Yeongseon Jang, Raehyun Kim, Kookheon Char, Jwa-Min Nam.   

Abstract

We developed a cell-based assay based on the spin-assisted layer-by-layer (LbL) assembled polyelectrolyte matrix platforms. Three types of human breast epithelial cell lines including normal cells (184B5), noncancerous fibrocystic disease cells (MCF 10F), and metastatic cancerous cells (CAMA-1) were cultured, analyzed, and compared in parallel on various LbL-assembled polymer films. Poly(allylamine hydrochloride) (PAH) and poly(acrylic acid) (PAA) electrolyte polymers were used as the basic building units to form various LbL polyelectrolyte matrices. The mechanical rigidity, surface charge, and biorecognition property of the LbL platforms were controlled by tailoring the LbL surface, thermal cross-linking, and protein modification. Cellular phenotypic changes in adhesion, proliferation, and morphology on these LbL films were characterized and analyzed for the three different cell types. Our analysis results indicate that the cellular phenotype can be controlled by taking advantage of different surface charge, mechanical property, and biological modification (i.e., fibronectin in this case) of the LbL multilayer platforms. Importantly, cell phenotypical quantification results show that the cell spreading area per cell and optical density are useful parameters in distinguishing metastatic cancer cells from normal or fibrocystic disease cells on these LbL films. These LbL-based cell assay platforms have a potential for the development of various disease diagnostic cell assays.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19572697     DOI: 10.1021/bm900439r

Source DB:  PubMed          Journal:  Biomacromolecules        ISSN: 1525-7797            Impact factor:   6.988


  1 in total

Review 1.  Polyelectrolyte multilayers in tissue engineering.

Authors:  Christopher J Detzel; Adam L Larkin; Padmavathy Rajagopalan
Journal:  Tissue Eng Part B Rev       Date:  2011-02-15       Impact factor: 6.389

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.